AMGEN
SKU: 50889
EVENITY is a sclerostin inhibitor indicated for the treatment of osteoporosis
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
Frequently Bought Together
More From AMGEN
Recently Viewed